Natco Pharma Ltd. | Ownership
Companies that own Natco Pharma Ltd.
Aditya Birla Sun Life AMC Ltd.
5,076,690
2.75%
114,300
0.45%
07/31/2018
Nomura Asset Management Singapore Ltd.
4,990,440
2.71%
2,960,597
0.98%
03/29/2018
The Vanguard Group, Inc.
2,843,057
1.54%
-12,320
0%
07/31/2018
Matthews International Capital Management LLC
2,424,712
1.31%
2,424,712
0.08%
06/30/2018
Jupiter Asset Management Ltd.
1,973,584
1.07%
-4,210
0.07%
02/28/2018
APG Asset Management NV
1,924,105
1.04%
1,924,105
0.01%
06/30/2018
Investment Professionals Ltd.
1,670,119
0.91%
-330,381
16.89%
03/31/2017
Morgan Stanley Investment Management, Inc.
1,475,440
0.8%
687,584
0.02%
06/30/2018
IDFC Asset Management Co. Ltd.
1,393,282
0.76%
0
0.52%
08/31/2018
Dimensional Fund Advisors LP
1,167,842
0.63%
85,861
0%
04/30/2018
| Address |
NATCO House
Hyderabad TS 500034
India
|
|
Employees
|
- |
| Website |
http://www.natcopharma.co.in |
| Updated |
07/08/2019 |
| NATCO Pharma Ltd. engages in the business of pharmaceuticals which comprises research and development, manufacturing and selling of bulk drugs and finished dosage formulations. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations is a leading player in India's oncology segment with 28 active brands. |
